Cavendish Laboratory, University of Cambridge, J.J. Thomson Avenue, Cambridge CB3 0HE, United Kingdom.
J Chem Phys. 2017 Sep 14;147(10):105103. doi: 10.1063/1.4995255.
The classical nucleation theory finds the rate of nucleation proportional to the monomer concentration raised to the power, which is the "critical nucleus size," n. The implicit assumption, that amyloids nucleate in the same way, has been recently challenged by an alternative two-step mechanism, when the soluble monomers first form a metastable aggregate (micelle) and then undergo conversion into the conformation rich in β-strands that are able to form a stable growing nucleus for the protofilament. Here we put together the elements of extensive knowledge about aggregation and nucleation kinetics, using a specific case of Aβ amyloidogenic peptide for illustration, to find theoretical expressions for the effective rate of amyloid nucleation. We find that at low monomer concentrations in solution and also at low interaction energy between two peptide conformations in the micelle, the nucleation occurs via the classical route. At higher monomer concentrations, and a range of other interaction parameters between peptides, the two-step "aggregation-conversion" mechanism of nucleation takes over. In this regime, the effective rate of the process can be interpreted as a power of monomer concentration in a certain range of parameters; however, the exponent is determined by a complicated interplay of interaction parameters and is not related to the minimum size of the growing nucleus (which we find to be ∼7-8 for Aβ).
经典成核理论发现成核速率与单体浓度的幂成正比,其中 n 是“临界核大小”。最近,一种替代的两步机制对淀粉样蛋白以同样的方式成核的隐含假设提出了挑战,当可溶性单体首先形成亚稳聚集体(胶束),然后转化为富含β-链的构象时,就会发生这种情况,这种构象能够形成原纤维的稳定生长核。在这里,我们结合了关于聚集和成核动力学的广泛知识,使用 Aβ 淀粉样肽的特定情况来说明,以找到淀粉样蛋白成核的有效速率的理论表达式。我们发现,在溶液中单体浓度较低的情况下,以及在胶束中两个肽构象之间的相互作用能量较低的情况下,成核是通过经典途径发生的。在更高的单体浓度和其他肽之间的一系列相互作用参数下,成核的两步“聚集-转化”机制会接管。在这个范围内,该过程的有效速率可以解释为在一定参数范围内单体浓度的幂;然而,指数由相互作用参数的复杂相互作用决定,与生长核的最小尺寸(我们发现 Aβ 的生长核尺寸约为 7-8)无关。